Cell MedX (OTCMKTS:CMXC) Shares Up 213.7% – What’s Next?

Shares of Cell MedX Corp. (OTCMKTS:CMXC) shot up 213.7% on Monday . The company traded as high as $0.16 and last traded at $0.16. 100 shares were traded during mid-day trading, a decline of 100% from the average session volume of 20,342 shares. The stock had previously closed at $0.05.

Cell MedX Price Performance

The firm’s 50-day moving average is $0.20 and its two-hundred day moving average is $0.09.

Cell MedX Company Profile

Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.